On Monday, Divi Laboratories consolidated net profit, which has been increased by 78 per cent to Rs 895 crore in the fourth quarter on March 31, 2022. In the last quarter, the drugmaker has reported a net profit of Rs 502 crore, and revenue from operation rose to Rs 2 518 crores, against Rs 1 788 crore in the year-ago period, as per the company’s statement.

• United Breweries Shares Hit 10% Upper Circuit on Stellar Q4 Update 
• PhonePe Indus Appstore Launched Voice Search Feature For Ten Indic Languages
• Hindustan Unilever Announced a 6% YoY Decline in Net Profit; Declared Interim Dividend 
• LTIMindtree Announced a 1.2% YoY Decline in Net Profit 
• Axis Bank Swings Into Profit with Strong Q4 Earnings; Declares Interim Dividend 

For the year ended in March 2022, Divi Laboratories Ltd posted a consolidated net profit of Rs 2,960 crore against Rs 1,984 crore in FY21.

Revenue from operations rose to Rs 8,960 crore compared to Rs 6,969 crore in 2020-21.
The company said its board had recommended a dividend of Rs 30 per share of the face value of Rs 2 (1,500 per cent) for 2021-22, subject to members’ approval at the ensuing annual general meeting.

Shares of the company were trading 6.37 per cent down at Rs 4,032.35 apiece on the Bombay Stock Exchange (BSE).